Guangxiu Tech Biotechnology

Guangxiu Tech Biotechnology, officially known as Hunan Guangxiu High-tech Life Science and Technology Co., Ltd., is a prominent Chinese biotechnology firm focused on the research, development, and clinical application of stem cell therapies. Founded by the pioneering scientist Lu Guangxiu, the company operates the National Engineering Research Center of Human Stem Cells and maintains one of the world's largest human embryonic stem cell (hESC) banks. Its therapeutic pipeline primarily utilizes human umbilical cord mesenchymal stem cells (hUC-MSCs) to target conditions such as psoriasis, which has reached Phase 1/2a clinical trials, and neurodegenerative disorders like Alzheimer's disease and age-related cognitive decline. The company integrates advanced cell reprogramming, GMP-compliant manufacturing, and genetic health services to provide a comprehensive full life cycle health platform.